FDA Approved: VALSARTAN — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmacuticals Inc.'s original ANDA for valsartan, a generic angiotensin II receptor blocker. The approval enables marketing of a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

ORIG AP for VALSARTAN (VALSARTAN)